Monkeypox Treatment Trial Begins in the Democratic Republic of the Congo
NIH partnering with INRB to evaluate tecovirimat (TPOXX). October 12, 2022 -- A clinical trial to evaluate the antiviral drug tecovirimat, also known as TPOXX, in adults and children with monkeypox has begun in the Democratic Republic of the... (Source: Drugs.com - Clinical Trials)
Source: Drugs.com - Clinical Trials - October 12, 2022 Category: Pharmaceuticals Source Type: clinical trials

Tecovirimat for Treatment of Monkeypox Virus
Condition:   Monkeypox Interventions:   Drug: Tecovirimat Oral Capsule;   Drug: Placebo Sponsors:   National Institute of Allergy and Infectious Diseases (NIAID);   Institut National de Recherche Biomédicale. Kinshasa, République Démocratique du Congo Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 29, 2022 Category: Research Source Type: clinical trials

Evaluation of Molecular Point-of-care Xpert ® Xpress SARS-CoV-2 Detection Implementation in Resource-limited Settings
Condition:   Screening of Patients With Symptoms Suggestive of SARS-CoV-2 Infection Intervention:   Device: Gene Expert molecular Point-of-Care (POC) (Xpert® Xpress SARS-CoV-2/Flu/RSV test Sponsors:   National Institute for Medical Research, Tanzania;   University of Kinshasa (UNIKIN), Congo, The Democratic Republic of the ( Prof Vivi Maketa);   Research Institute for Health Sciences - Burkina Faso, Burkina Faso (Dr Marc Christian Tahita);   Universiteit Antwerpen, Belgium (ProfJean-P ierre Van geertruyden);   Københavns Universitet (UCPH), Denmark (Prof Michael Alifrangis);   Universidad de Valencia, Spain ...
Source: ClinicalTrials.gov - August 25, 2022 Category: Research Source Type: clinical trials

Evaluation of Molecular Point-of-care Xpert ® Xpress SARS-CoV-2 Detection Implementation in Resource-limited Settings
Condition:   COVID-19 Intervention:   Device: Gene Expert molecular Point-of-Care (POC) (Xpert® Xpress SARS-CoV-2/Flu/RSV test Sponsors:   National Institute for Medical Research, Tanzania;   University of Kinshasa (UNIKIN), Congo, The Democratic Republic of the ( Prof Vivi Maketa);   Research Institute for Health Sciences - Burkina Faso, Burkina Faso (Dr Marc Christian Tahita);   Universiteit Antwerpen, Belgium (ProfJean-P ierre Van geertruyden);   Københavns Universitet (UCPH), Denmark (Prof Michael Alifrangis);   Universidad de Valencia, Spain (Prof Fernando Gonzalez-Candelas) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 25, 2022 Category: Research Source Type: clinical trials